HSIC.NASDAQHenry Schein INC

10-Q: Henry Schein Reports Mixed Q3 Results Amid Cyber Incident Recovery and Restructuring

Sentiment:

Quarterly Report


Henry Schein's Q3 results show a slight increase in net sales, but the company is still navigating the impact of a cyber incident and implementing restructuring plans.

Worse than expectedThe company's operating income and net income decreased year-over-year, indicating worse than expected results.The company's dental and medical distribution businesses experienced a sales decrease due to the cyber incident, which was worse than expected.

Summary

  • Henry Schein's net sales for the third quarter of 2024 were $3.174 billion, a slight increase from $3.162 billion in the same period last year.
  • The company's operating income decreased to $157 million from $200 million year-over-year.
  • Net income attributable to Henry Schein, Inc. was $99 million, down from $137 million in the third quarter of 2023.
  • The company experienced a sales decrease in its dental and medical distribution businesses, primarily due to lower sales to episodic customers following a cyber incident in October 2023.
  • Expenses directly related to the cyber incident were $1 million for the quarter and $9 million for the nine months ended September 28, 2024.
  • Henry Schein received insurance proceeds of $10 million for the quarter and $20 million for the nine months ended September 28, 2024, as partial recovery for losses related to the cyber incident.
  • The company committed to a new restructuring plan in August 2024, incurring $36 million in charges during the quarter.
  • The company's effective tax rate was 24.7% for the quarter and 25.1% for the nine months ended September 28, 2024.
  • The company repurchased 1,954,076 shares of common stock during the quarter.

Sentiment

Score: 4

Explanation: The document presents mixed results with a slight increase in net sales but a decrease in profitability and ongoing challenges from a cyber incident and restructuring. The sentiment is cautiously negative due to the decrease in profitability and the ongoing impact of the cyber incident.

Positives

  • Net sales saw a slight increase year-over-year.
  • The technology and value-added services segment showed a 5.1% increase in net sales for the quarter and 9.7% for the nine months ended September 28, 2024.
  • The company received $10 million in insurance proceeds for the quarter and $20 million for the nine months ended September 28, 2024, related to the cyber incident.
  • The company continues to repurchase shares, with 1,954,076 shares repurchased during the quarter.

Negatives

  • Operating income decreased from $200 million to $157 million year-over-year.
  • Net income attributable to Henry Schein, Inc. decreased from $137 million to $99 million year-over-year.
  • The company experienced a decrease in sales in its dental and medical distribution businesses due to the cyber incident.
  • The company incurred $1 million in expenses related to the cyber incident for the quarter and $9 million for the nine months ended September 28, 2024.
  • The company recorded $36 million in restructuring charges related to a new restructuring plan.

Risks

  • The company is still recovering from the cyber incident, which has impacted sales in the dental and medical distribution businesses.
  • The new restructuring plan may result in additional charges in the fourth quarter of 2024 and in 2025.
  • The company is subject to various legal proceedings, including opioid-related lawsuits and a class action lawsuit related to the cyber incident.
  • The company's effective tax rate may be impacted by future tax reforms.
  • The company's ability to generate sufficient cash flows from operations is dependent on the continued demand of our customers for our products and services, and access to products and services from our suppliers.

Future Outlook

The company expects to record immaterial charges associated with the 2022 Plan during the remainder of 2024 and restructuring charges associated with the 2024 Plan during the fourth quarter of 2024 and in 2025, however an estimate of the amount of these charges has not yet been determined. The company plans to continue to accelerate its share repurchase activity in light of its favorable cash position.

Management Comments

  • The company believes that it is the world's largest provider of health care products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care.
  • The company believes that it has a strong brand identity due to its more than 92 years of experience distributing health care products.
  • The company is focused on building relationships with decision makers who do not reside in the office-based practitioner setting.
  • The company is focused on building relationships with decision makers who do not reside in the office-based practitioner setting.
  • The company believes that consolidation within the industry will continue to result in a number of distributors, particularly those with limited financial, operating and marketing resources, seeking to combine with larger companies that can provide growth opportunities.

Industry Context

The health care industry is experiencing consolidation, with practitioners increasingly partnering with larger entities. The industry is also seeing a focus on cost containment, which benefits distributors capable of providing a broad array of products and services at low prices. The aging population and increased health care awareness are also driving growth in the industry.

Comparison to Industry Standards

  • Henry Schein's performance is mixed when compared to industry standards, with a slight increase in net sales but a decrease in profitability.
  • The company's technology and value-added services segment is performing well, which is in line with the industry trend of increasing demand for technology solutions.
  • The impact of the cyber incident on the company's sales is a unique challenge that is not necessarily reflected in industry benchmarks.
  • The company's restructuring efforts are similar to those of other companies in the industry that are seeking to streamline operations and increase efficiency.
  • The company's debt levels are relatively high, which is a common characteristic of companies in the distribution industry that have made acquisitions.

Legal Proceedings

  • Henry Schein, Inc. has been named as a defendant in multiple opioid related lawsuits.
  • Henry Schein received a Grand Jury Subpoena from the United States Attorneys Office for the Western District of Virginia, seeking documents in connection with an investigation of possible violations of the Federal Food, Drug & Cosmetic Act by Butler Animal Health Supply, LLC.
  • A putative class action was filed against the Company in the U.S. District Court for the Eastern District of New York (EDNY), Case No. 24-cv-387 (the Cruz-Bermudez Action), based on the October 2023 cyber incident.
  • Henry Schein, Inc. and its subsidiary, North American Rescue, LLC (NAR), were named as defendants in a qui tam lawsuit brought under the federal False Claims Act (FCA).

Related Party Transactions

  • The company has a ten-year royalty agreement with Internet Brands, paying approximately $31 million annually for the use of their intellectual property.
  • The company recorded net sales of $14 million and $38 million respectively, to entities accounted for under the equity accounting method during the three and nine months ended September 28, 2024.
  • The company purchased $2 million and $8 million respectively, from entities accounted for under the equity accounting method during the three and nine months ended September 28, 2024.
  • Certain of the company's facilities related to acquisitions are leased from employees and minority shareholders.

Stakeholder Impact

  • Shareholders may be concerned about the decrease in profitability and the ongoing impact of the cyber incident.
  • Employees may be affected by the restructuring plans.
  • Customers may experience disruptions in service due to the cyber incident.
  • Suppliers may be impacted by changes in the company's purchasing patterns.
  • Creditors may be concerned about the company's debt levels.

Next Steps

  • The company will continue to implement its restructuring plans.
  • The company will continue to work on recovering from the cyber incident.
  • The company will continue to evaluate possible candidates for joint venture or acquisition.
  • The company plans to continue to accelerate its share repurchase activity.

Key Dates

DateDescription
December 24, 2012Date of a private placement facility borrowing.
June 16, 2017Date of a private placement facility borrowing.
September 15, 2017Date of a private placement facility borrowing.
January 2, 2018Date of a private placement facility borrowing.
September 2, 2020Date of a private placement facility borrowing.
August 20, 2021Date the company entered into a $1.0 billion revolving credit agreement.
June 2, 2021Date of two private placement facility borrowings.
August 1, 2022Date the company committed to the 2022 restructuring plan.
May 4, 2023Date of four private placement facility borrowings.
July 5, 2023Date the company acquired S.I.N. Implant System.
July 11, 2023Date the company amended and restated the Revolving Credit Agreement and entered into a three-year $750 million term loan credit agreement.
October 2, 2023Date the company acquired Shield Healthcare, Inc.
October 2023Henry Schein experienced a cyber incident.
November 22, 2023Henry Schein experienced a disruption of its ecommerce platform and related applications.
January 18, 2024A putative class action was filed against the Company in the U.S. District Court for the Eastern District of New York (EDNY), Case No. 24-cv-387 (the Cruz-Bermudez Action).
April 1, 2024Date the company acquired a 60% voting equity interest in TriMed Inc.
August 6, 2024Date the company committed to the 2024 restructuring plan.
September 13, 2024Plaintiffs and the Company entered into a class action settlement agreement on September 13, 2024.
September 16, 2024The court preliminarily approved the settlement on September 16, 2024.
September 28, 2024End of the reporting period for the quarterly report.
October 28, 2024Date of outstanding shares of the registrants common stock.
February 14, 2025The court has scheduled a fairness hearing on the proposed settlement for February 14, 2025.
September 2025The action filed by Florida Health Sciences Center, Inc. (and 25other hospitals located throughout the State of Florida) in Florida state court, which is currently scheduled for a jury trial in September 2025.

Keywords

Henry Schein, cyber incident, restructuring, net sales, operating income, net income, dental, medical, technology, value-added services, insurance, stock repurchase, legal proceedings

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.